- Poster Session
Posters 1: Urinary Incontinence and Voiding Dysfunction

Saturday June 25, 2022 | 16:00 to 17:30
Room: Ash

Learning Objectives

As a result of attending this session, participants will be able to:

  • Discover cutting edge research for diagnosing and treating male and female voiding dysfunction.
  • Expand your knowledge on the outcomes of new and reinvigorated technology for the treatment of urinary incontinence.
  • Network with like-minded functional urology colleagues.


Presentations


16:30
MP-1.2

Dr. / Dr Okechukwu E Abara
Use of sound waves through smartphone to monitor urinary flow patterns among rural northern Ontario residents — a potential digital health strategy?


16:34
MP-1.4

Dr. / Dr Sender Herschorn
Treatment patterns in men prescribed benign prostatic obstruction or overactive bladder medications: a Canadian retrospective population-based study


16:38
MP-1.5

Dr. / Dr Katherine Anderson
Quality-of-life outcomes following endoscopic excision of female stress urinary incontinence mesh and pelvic organ prolapse mesh


16:42
MP-1.6

Dr. / Dr Katherine Anderson
Long-term effect of sacral neuromodulation on nocturia for patients with refractory overactive bladder


16:46
MP-1.7

Mr. / M. Samuel Farag
Analyzing outcomes of the Adjustable Transobturator Male System (ATOMS) for post-prostatectomy incontinence and its relationship with overactive bladders and radiotherapy


16:50
MP-1.8

Ms. / Mme Aalya Hamouda
Antagonism of the p75NTR receptor decreases the extracellular activity of matrix metalloproteinase-9 and increases secretion of nerve growth factor by mouse urothelial cells in culture


16:54
MP-1.9

Dr. / Dr Carolyn MacLeod
A systematic review of decision aids for patients with lower urinary tract dysfunction


16:58
MP-1.10

Mrs. / Mme Fatemah Hussain
Sacral neuromodulation outcomes in male patients with overactive bladder (neurogenic and non-neurogenic)


17:02
MP-1.11

Dr. / Dr James Ross
Intravesical botulinum toxin: practice patterns and barriers to delivery from a survey of Canadian urologists


17:06
MP-1.12

Mr. / M. Peter Gariscsak
Urologist-perceived barriers and perspectives on the underuse of sacral neuromodulation for overactive bladder in Canada



MP-1.14

Dr. / Dr Mélanie Aubé-Peterkin
Does size matter? Long-term outcomes after treatment of bulbar urethral strictures with the Optilume drug-coated balloon


17:14
MP-1.15

Dr. / Dr Blayne Welk
The relative importance of different consequences of nocturnal enuresis among older women: a conjoint analysis experiment




© 2024 CUA 77th Annual Meeting